ARS Pharmaceuticals, Inc (SPRY) — Cash Flow Quality Index
ARS Pharmaceuticals, Inc (SPRY) has a Cash Flow Quality Index of 0.84x as of December 2024. Operating cash flow of $42.00 Million is below net income of $49.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore SPRY cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ARS Pharmaceuticals, Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for ARS Pharmaceuticals, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of ARS Pharmaceuticals, Inc.
Annual Cash Flow Quality Index for ARS Pharmaceuticals, Inc (2024–2024)
Year-by-year earnings quality comparison for ARS Pharmaceuticals, Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.69x | $13.55 Million | $8.00 Million | — |